0000352998-21-000009.txt : 20210722 0000352998-21-000009.hdr.sgml : 20210722 20210722162522 ACCESSION NUMBER: 0000352998-21-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210721 FILED AS OF DATE: 20210722 DATE AS OF CHANGE: 20210722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pate R Carter CENTRAL INDEX KEY: 0001641406 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08568 FILM NUMBER: 211107907 MAIL ADDRESS: STREET 1: 5739 WORTHAM LANE CITY: DALLAS STATE: TX ZIP: 75252 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teligent, Inc. CENTRAL INDEX KEY: 0000352998 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 010355758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 BUSINESS PHONE: 856.697.1441 MAIL ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 FORMER COMPANY: FORMER CONFORMED NAME: IGI LABORATORIES, INC DATE OF NAME CHANGE: 20100408 FORMER COMPANY: FORMER CONFORMED NAME: IGI INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGENETICS INC DATE OF NAME CHANGE: 19870814 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2021-07-21 0 0000352998 Teligent, Inc. TLGT 0001641406 Pate R Carter C/O TELIGENT, INC. 105 LINCOLN AVENUE BUENA NJ 08310 1 0 0 0 Restricted Stock Units 2021-07-21 4 A 0 150000 0 A 2022-07-21 Common Stock 150000 150000 D Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The shares underlying the derivative securities shall vest fully on the first anniversary of grant. Each non-employee director of the Issuer is entitled to receive an annual grant of restricted stock units ("RSUs") with a value of $75,000 on the date of grant, such grants to be effective as of the date of the 2021 annual meeting of stockholders, and annually thereafter. The closing price of the Issuer's common stock on the date of grant was $0.50. /s/ R. Carter Pate 2021-07-22